IFNA1 and cancer: Notably, the ‘nuclear factor kappa light chain enhancer of activated B cells’ (NFκB) pathway and the interferon (IFN)-stimulated genes (ISG)/IFN pathway are recognized as the two broadest inflammatory pathways modulating cancer immunity as well as metastatic risk.